Key result
Planned cohort evaluates the association of time-weighted average lactate during CPB with 30-day infection risk.
Why the study?
Prospective evidence linking intraoperative lactate accumulation during cardiopulmonary bypass to postoperative infection risk remains limited.
Does time-weighted average lactate during cardiopulmonary bypass ≥2.0 mmol/L increase postoperative infection in adult patients undergoing elective cardiac surgery with CPB?
Cohort (n=346)
Single-blind
No
Does time-weighted average lactate during cardiopulmonary bypass ≥2.0 mmol/L increase postoperative infection in adult patients undergoing elective cardiac surgery with CPB?
This protocol outlines a prospective cohort study to evaluate whether time-weighted average lactate during cardiopulmonary bypass can serve as an early indicator for postoperative infection risk in cardiac surgery patients.
Prospective cohort will test lactate during CPB as infection predictor; hypothesis-generating and should not yet change practice.
Introduction: During cardiopulmonary bypass (CPB), impaired perfusion, ischemia-reperfusion injury, and systemic inflammation frequently result in lactate accumulation. Lactate is routinely monitored perioperatively and may serve as an early indicator of postoperative infection, yet prospective evidence linking intraoperative lactate to infection risk remains limited. This prospective cohort study aims to evaluate the association between the time-weighted average (TWA) lactate during CPB and the risk of postoperative infection in patients undergoing cardiac surgery. Methods: This single-center, prospective cohort study will enroll 346 adult patients undergoing elective cardiac surgery with CPB. Arterial blood samples will be obtained at multiple intraoperative time points to calculate TWA lactate. Patients will be classified into exposure and non-exposure groups based on a TWA lactate cutoff of ≥2.0 mmol/L. The primary outcome is the incidence of infection within 30 days of surgery. A predefined directed acyclic graph will guide covariate adjustment. Multivariable logistic regression will estimate the risk association, and restricted cubic spline models will explore potential nonlinear relationships. Sensitivity analyses will use lactate load, defined as the area under the lactate-time curve during CPB, to examine whether cumulative intraoperative lactate exposure yields results consistent with those obtained using TWA. Discussion: This prospective cohort study aims to investigate the association between time-weighted average lactate during cardiopulmonary bypass and postoperative infection risk in cardiac surgery patients. If the hypothesis is confirmed, TWA lactate could serve as a readily available marker for intraoperative risk stratification, facilitating early identification of high-risk patients and guiding individualized interventions. The findings may provide evidence for optimizing perioperative management and improving clinical outcomes. As a single-center study, external validation in multicenter settings will be needed to enhance generalizability. Clinical Trial Registration: https://www.chictr.org.cn, identifier ChiCTR2500110269.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) conducted a cohort in Elective cardiac surgery with cardiopulmonary bypass (n=346). Time-weighted average lactate ≥2.0 mmol/L during cardiopulmonary bypass vs. Time-weighted average lactate <2.0 mmol/L was evaluated on Incidence of infection within 30 days of surgery. Time-weighted average lactate during cardiopulmonary bypass will be evaluated for its association with 30-day postoperative infection risk in a planned prospective cohort of 346 cardiac surgery patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: